English Korean Chinese
ホーム > ニューズレター > 医薬品 > Autoimmune Drug Focus (ADF)
ニューズレターカテゴリ
バイオテクノロジー (11)
医薬品 (28)
医療機器 (7)
通信/IT (62)
電子部品/半導体 (7)
自動車 (5)
エネルギー (7)
環境 (4)
防衛/航空宇宙 (7)
マテリアル (21)
産業用機械 (1)
建築/土木 (3)
金融/保険 (27)
食料/飲料 (21)
一般消費財 (12)
ニューズレター

Autoimmune Drug Focus (ADF)

発行 Espicom Business Intelligence
発行回数 12 回/年 商品コード 26341
ページ情報 英文  
価格
US$ 1,025 換算 ¥ 82,492 (税抜) 1 Year Web Access (Single User License)
US$ 1,025 換算 ¥ 82,492 (税抜) 1year Hard Copy
US$ 1,025 換算 ¥ 82,492 (税抜) 1year PDF by e-mail


原文目次

    

Do you want to keep up-to-date with all the latest developments in this important and high-value pharmaceutical area? Autoimmune Drug Focus (ADF) provides a simple, time-saving way to do just that. It summarises all the latest developments in an easy-to-read format, providing company and drug indexes as well as information on future conferences. Can you afford to be without it?

With approximately 4% of the population suffering from an autoimmune disease and the prevalence of these disorders rising, it is unsurprising that each year, millions of dollars are devoted to researching the causes of autoimmune disorders.

 Regular sections in ADF include:

  • Diabetes
  • Inflammatory Bowel Diseases (with features on Crohns disease and ulcerative colitis)
  • Multiple Sclerosis
  • Musculoskeletal Disorders (with features on rheumatoid arthritis, lupus and more)
  • Psoriasis
  • General Developments?
Back to Top